GHK-Cu: What Is It and What Does It Do?

GHK-Cu is a naturally occurring copper-binding peptide, first isolated from human blood plasma in the early 1970s and now common in skincare. Small human trials of topical creams and serums suggest modest improvements in skin appearance, but those trials are generally small and funded by the cosmetic industry. Evidence for hair growth and wound healing is thinner and comes mostly from lab and animal studies, and there are no published human data showing that injecting GHK-Cu is safe or effective (reference 3). This guide separates what has been studied from what is being marketed, and explains why injectable "peptide" versions are a different kind of risk.

At a Glance

  • What it is: A three-amino-acid peptide (glycyl-L-histidyl-L-lysine) that binds copper. On ingredient lists it often appears as "Copper Tripeptide-1."
  • Best-supported use: Topical products for the appearance of aging skin, with modest results in small trials.
  • Weaker evidence: Hair growth and wound healing, mostly preclinical or preliminary.
  • No human safety or efficacy data: Self-injected GHK-Cu, especially from online sellers.
  • Not a drug: GHK-Cu is not FDA-approved as a treatment for skin aging, hair loss, wounds, or any other condition.

What GHK-Cu Is

GHK is a small peptide found in human plasma that can also be released from tissue after injury. It binds copper strongly, which is why it is usually called GHK-Cu. Its discoverer, chemist Loren Pickart, reported in the early 1970s that blood from younger adults seemed to revive liver cells in the lab, and that GHK levels appear to decline with age (reference 3). Those age-related figures come largely from his group's early work, so treat exact numbers as reported rather than established.

NameWhat it means
GHKThe peptide alone (glycyl-L-histidyl-L-lysine)
GHK-CuThe peptide bound to copper
Copper Tripeptide-1The common ingredient-list name in cosmetics

What the Evidence Shows, by Use

UseWhat it is based onConfidence
Topical, for skin appearanceSmall human trials, generally industry-funded, reporting improvements in skin thickness and elasticity and fewer wrinkles (reference 3). Cell studies also show increased collagen and elastin production (reference 1).Low to moderate
Topical or scalp, for hairPreliminary studies and small trials. Established treatments such as minoxidil and finasteride have far more evidence.Low
Wound healingMostly animal and lab studies. Human data are limited.Low
"Longevity" or whole-body effectsAnimal studies onlyVery low
Self-injectedNo published human studies showing safety or effectivenessNone

What the research can and cannot show

  • Lab results are not treatment effects. A peptide that raises collagen in cultured cells has not necessarily improved a wrinkle on a person.
  • Much of the supportive literature has a conflict of interest. The main review papers are written by the peptide's discoverer (reference 1). Look for independent replication, not just citations of the same group.
  • Trials are small and short. Results depend on the product's concentration and formulation, which differ from commercial serums.
  • Skin penetration is limited. Applying a peptide to the surface does not guarantee it reaches the deeper layers where collagen is made.

Using a Topical GHK-Cu Product

If you want to try one, treat it as a cosmetic ingredient with modest, gradual effects at best. Labels usually don't tell you how much active peptide a serum contains, so there is no reliable way to compare products by "strength."

StepWhy it matters
Patch test on a small area for a few daysChecks for redness, stinging, or an allergic reaction before you apply it to your whole face
Add one new product at a timeLets you tell what is helping or irritating
Take photos in the same light every few weeksTrials ran weeks to months, so subtle changes are hard to judge by eye
Keep using sunscreenSun protection is better supported for skin aging than any peptide
Avoid broken or inflamed skinIrritation is more likely, and absorption is unpredictable

Reasonable expectations: subtle changes in texture or firmness over a couple of months, if at all, not "skin regeneration" or a replacement for procedures. Consider a trial of about two to three months, judged against your photos. That timeline is a practical suggestion, not a research-derived prescription.

Troubleshooting

What you noticePossible causeWhat to try
Redness, stinging, or itchingIrritation or a reaction to the peptide or another ingredientStop and wait for skin to calm. Restart with a patch test or ask a dermatologist.
No visible change after a few monthsSmall effect, low concentration, or unstable formulaDon't escalate to stronger or riskier products. Consider stopping.
Skin condition such as rosacea or eczemaBarrier already sensitiveAsk a dermatologist before adding active ingredients
Thinning hair or patchy hair lossMany possible causes, some medicalSee a dermatologist rather than relying on a serum

Injectable and Grey-Market GHK-Cu

Injected GHK-Cu is a different category. The topical studies do not tell us anything about the safety of injection, which bypasses the skin barrier. Dermatologists quoted by NPR in September 2026 were advising patients to hold off on injecting any copper peptide until human studies exist, and pointed to concerns about unregulated suppliers, with no assurance about quality or dose (reference 3).

  • FDA concerns: The FDA has said compounded injectable GHK-Cu may pose a risk of immune reactions from peptide aggregation and impurities (reference 2). Experts also raise the possibility of too much copper.
  • Regulatory status is in flux: As of early September 2026, compounding pharmacies in the U.S. were not technically permitted to offer injectable GHK-Cu, and an FDA advisory committee was scheduled to review it again in February (reference 3). Check the FDA's current list before relying on anything here.
  • Reported problems: One clinician told NPR he sees injection-site irritation and infections and, in some patients who self-injected, elevated liver enzymes and copper. These are anecdotal and it is unclear whether the peptide or impurities were responsible (reference 3).
  • "Stacks": Mixing peptides makes it impossible to know which ingredient caused a problem.

Get medical help if you develop fever, spreading redness, severe pain, yellowing of the skin or eyes, or an allergic reaction after injecting any unregulated product.

Who Should Check With a Doctor First

  • Anyone considering injections or any non-topical form
  • People who are pregnant or breastfeeding (safety data are lacking)
  • Anyone with a copper-metabolism disorder, liver disease, or a history of severe skin reactions
  • Anyone with a skin condition or hair loss they haven't had evaluated

Example: Deciding What to Do

Someone sees a social media post about copper peptides and wants firmer skin. The reasonable route is a topical serum from a transparent brand, a patch test, daily sunscreen, and photos every few weeks over a couple of months. If the post is pushing injectables from an online seller, the gap between what is claimed and what is known is large, so the sensible step is to skip it and speak to a dermatologist about options with real evidence.

Frequently Asked Questions

Does GHK-Cu work for anti-aging?

Small, mostly industry-funded trials suggest modest improvements in skin appearance with topical products. It is not a proven anti-aging treatment, and it does not replace sun protection.

Does GHK-Cu grow hair?

Evidence is preliminary. It is not a substitute for approved treatments such as minoxidil or finasteride. See a dermatologist for hair loss.

Is GHK-Cu FDA-approved?

Not as a drug for any condition. It is used as a cosmetic ingredient, and injectable versions have drawn FDA safety concerns.

Is it safe to inject GHK-Cu?

No published human studies show that it is safe or effective, and online products may be mislabeled or contaminated. Dermatologists interviewed by NPR advise against it for now.

How long does it take to see results from a serum?

Effects, if any, are gradual. A couple of months with photos is a fair trial, but results vary.

References

  1. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 2018;19(7):1987. pmc.ncbi.nlm.nih.gov/articles/PMC6073405
  2. U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. fda.gov
  3. Stone W. The copper peptide trend has gone from creams to injections, ahead of the science. NPR, September 7, 2026. npr.org
This article is general educational information and not a substitute for personal medical advice.